⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Chronic Heart Failure Clinical Trial Pipeline Shows Potential with Active Contributions from 25+ Key Companies | DelveInsight
globenewswire.com
CYTK
BAYRY
LLY
BCDA
MESO
TNSA
NVO
AZN
BMY
ITCI
JNJ
AMGN
ARWR
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
globenewswire.com
NVO
Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer's Research and Suggests Potential for Combination Therapies
prnewswire.com
NVO
GEHC
Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital Diabetes Management Transform Patient Care
prnewswire.com
NVO
SNY
LLY
MDT
INSY
TNDM
More Muscle, Less Belly Fat Slows Brain Aging
prnewswire.com
NVO
9amHealth to Expand Access to Obesity Management Treatment through New Employer Health Benefits Offering
prnewswire.com
LLY
NVO
Waltz Health Launches New Direct-to-Employer Access Model for Obesity Management Medications
prnewswire.com
NVO
LLY
Breakthrough Discovery in AI and Quantum Computing From SiC Systems Wins 2025 HPC Innovation Excellence Award
accessnewswire.com
ORCA
NVO
GOOG
Quantinuum
Pfizer Addresses Proposal for Metsera
businesswire.com
PFE
NVO
MTSR
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
NVO